Updates on the Valsartan Litigation

Reg Reinoso

Author

July 2024 Valsartan Litigation Case Update from Attorney Mikal Watts

Attorney Mikal Watts continues to represent clients in the ongoing Valsartan litigation and provides this update concerning recent developments and the next steps. Although there have been some delays, notably with the trial originally scheduled for March, optimism remains high for the resolution of these cases.

Significant changes have occurred in the case’s oversight, with U.S. District Judge Renee Bumb taking over from Judge Kugler due to health/personal reasons. The first status conference with the new judge is scheduled for July 23, 2024, and the Plaintiff Steering Committee (PSC) is optimistic about maintaining a 2024 trial date for settlement discussions.

Throughout this transitional phase, it is crucial for clients to stay engaged and promptly respond to any requests from our firm or the MDL administration. Keeping your contact information up to date is essential for effective communication. Clients should ensure that we have your current address, phone numbers, and email addresses, including those of your spouse and heirs.

Striving for Systemic Change in the Pharmaceutical Industry

At Watts Law Firm LLP,  we are dedicated to holding pharmaceutical companies accountable for their actions. This litigation is part of our broader mission to ensure that pharmaceutical practices do not compromise patient safety.

Our firm’s involvement in the Valsartan litigation underscores our commitment to systemic change in the pharmaceutical industry, advocating for transparency and safety in all drug manufacturing and distribution practices. By pursuing this case, we aim not only to secure compensation for those harmed but also to foster industry-wide improvements that prioritize patient health over corporate profits.

As we navigate through the complexities of this litigation, we remain committed to providing our clients with the highest level of legal representation and support. Your trust in Watts Law Firm LLP motivates us to strive for justice and accountability in the pharmaceutical industry, ensuring that such oversights are not repeated.